Prostate cancer is the most commonly diagnosed malignancy in the American men and the second leading cause of male cancer death in the United States. Despite its high incidence, the molecular and genetic events involved in prostate cancer progression remain poorly understood. A hurdle in understanding the molecular genetic changes in prostate cancer has been the dif®culty in establishing premalignant lesions and primary prostate tumors as in vitro cell cultures. Primary epithelial cells grow for a ®nite life span and then senesce. Immortalization is de®ned by continuous growth of otherwise senescing cells and is believed to represent an early stage in tumor progression. In order to examine these early stages, we and others have developed in vitro models of prostate epithelial cell immortalization. Because prostate cancer is a multistep, progressive disease with a typical onset later in life and with an unusually high number of latent cases that do not develop into clinically manifest cancer, the steps in the progression to malignancy are of particular interest. To understand the many factors that are suspected to contribute to the development of this malignancy, there is a need for an in vitro multistep human prostate epithelial (HPE) culture system. These models have been extremely important in identifying genetic and molecular changes involved in prostate cancer progression. Prostate Cancer and Prostatic Diseases (2000) 3, 229±235.
Introduction
Prostate cancer is the most common male cancer in the US, as well as in the Western World, and the second leading cause of male cancer death in the US. 1 The recent progress made in identifying prostate cancer genes and understanding prostate cancer genetics has been impressive. However, the basic mechanisms underlying prostate carcinogenesis remain poorly understood. 2 The genetic and environmental factors responsible for the high incidence of prostate cancer are largely unknown. Although mutations have been observed in a wide variety of oncogenes and tumor suppressor genes in prostate cancer, a site-speci®c model for prostate cancer has not emerged.
The dif®culty in studying prostate cancer at the molecular level has been due to the following factors: (1) although several human prostate cancer cell lines (LNCaP, DU-145, and PC-3 and TSU-Pvl) are available, normal or immortalized human prostate epithelial (HPE) cell cultures have not been available as controls until only recently; (2) these prostate cancer cell lines are heterogeneous in origin and have different growth properties, including hormone responsiveness, which make comparison of gene expression very dif®cult; and (3) given the small size and cell type heterogeneity of prostate gland, direct work with these specimens has been dif®cult as well. Thus, a stepwise HPE cell culture system for studying the many factors suspected to contribute to the development of this cancer is necessary. In this paper, we describe the establishment of these models and their relevance to understanding the molecular and genetic changes that occur in prostate cancer.
In vitro human prostate cell models
In vitro cell culture models of human prostate carcinogenesis have not been widely available or well characterized until recently. Table 1 shows in chronological order the history of human prostate epithelial cell transformation. Efforts spanning more than a half a century, since the pioneering work of Burrows et al, 3 have produced only a few cell lines derived from normal prostate epithelium. To date, only four readily available and well-studied longterm human prostate carcinoma cell lines exist (DU145, PC-3, LNCaP and TSU-Prl). All four were isolated from metastatic lesions, thus leaving a void in reagents representing long-term human cell lines derived from primary localized adenocarcinoma of the prostate. Nevertheless, their use has greatly contributed to our current understanding of human prostate carcinogenesis and progression. As a result of a better understanding of the process of malignant transformation, and the availability of recombinant DNA technology, new cell lines have been developed and characterized during the past few years. Serum-free media for growth and maintenance of primary normal and malignant prostate epithelial cells have been developed. 4, 5 We have, for the ®rst time, found that serum-free growth media developed for human keratinocyte serum-free medium (K-SFM, Gibco, Grand Island, NY) are useful for growing and maintaining primary HPE cells and for the cultivation of short-term cultures of prostate HPE cells. 6, 7 Immortalization of HPE cells by SV40
Immortalization of human cells in culture by simian papovavirus 40 (SV40) is a widely used experimental method to generate long-term cell lines for the study of malignant disease. Most SV40 immortalized human cells fail to form tumors when implanted into athymic nude mice. The ®rst serum-free HPE cell line was established by using SV40 (Table 1) . Although Kaighn et al 8 reported the transformation of neonatal prostate epithelial cells to immortality with SV40 genes in 1989, only recently has the transformation of adult prostate epithelial cells by the large T-antigen gene of SV40 been achieved. In 1991, Cussenot et al 9 described the establishment of a cell line after liposome-mediated transfection of normal adult prostatic cells with the plasmid pMK161/SV40ori-. This cell line, PNT 1 , was not tumorigenic. Cells are anchoragedependent and androgen receptor positive, but do not show a growth response to 5a-DHT in medium containing growth factors and 2% horse serum. Responses to individual growth factors were not reported. Prostatespeci®c antigen (PSA) was only detected in normal parent and early passage immortalize cells but was not detected in PNT 1 after passage 10. When we began our work to develop adult HPE cell models, there had been only one report on the immortalization of such cells by SV40. Previous attempts to immortalize adult HPE cell have been dif®cult. 9 Strontium phosphate transfection has been successfully used to immortalize neonatal prostatic epithelial cells using a plasmid containing the SV40 early region genes, 8 but has failed when used on adult cells. 9 We have succeeded in immortalizing adult HPE cells by polybrene-induced DNA transfection of a plasmid containing an origin-defective SV40 genome together with a plasmid carrying the neomycin resistance gene. 6 Polybrene, in conjunction with dimethyl sulfoxide (DMSO) shock has been shown to increase the frequency of DNA transfection of mammalian cells, including human epidermal keratinocytes, as compared with the frequency obtained with calcium phosphate-mediated transfection. 10 ± 12 Normal adult HPE cells derived from prostate of a 53-y-old man undergoing radical prostatectomy were transfected by polybrene-induced gene transfer with a plasmid pRNS-1 containing an origin-defective SV40 genome and a plasmid carrying the neomycin resistance gene. The pRNS-1 transfected cells (pRNS-1-1) have been grown for more than 50 passages. These cells express SV40 T-antigen and are not tumorigenic in nude mice. They express cytokeratin 5 and 8, and are pseudodiploid. PSA expression was detected in parent and early passages. Growth was stimulated by EGF, IGF and bovine pituitary extract, but inhabited by TGF-b; they had lost together the ability of normal cells to be inhibited by tumor necrosis factor-a and 1,25 (OH) 2 vitamin D 3 . Therefore, immortalization appeared to have altered the growth-inhabitory but not the growth stimulatory mechanisms.
Primary epithelial cell cultures (BPH-1) were immortalized by infection with the plasmid ZipneoSV, carrying the SV-40 T-antigen gene. 13 These cells are nontumorigenic in nude mice. They express the SV40 large T-antigen Epithelial cells isolated from the prostate of a Caucasian man undergoing radical cystoprostatectomy were immortalized by infection with the Ad12-SV40 hybrid virus. 14 Cells are maintained in low-calcium, serum-free, chemically de®ned medium K-SFM (Gibco). This cell line (PWR-1E) has been extensively characterized. Cells are aneuploid and show growth response to 5a-DHT, as well as to the synthetic androgen mibolerone; they also show positive immunostaining for AR and for PSA after exposure to mibolerone. Growth is stimulated by EGF and bFGF, but inhibited by TGF-b. They are positive for SV40 T-antigen and p53, and are not tumorigenic in nude mice.
Immortalization of HPE cells by human papilloma virus (HPV)
HPV has been used to transform a variety of human epithelial cells in culture, including cervical and breast cells. 15, 16 Generally, human epithelial cells immortalized by HPV are not tumorigenic. 17 Chromosomal changes occur in HPV-immortalized cells and additional speci®c changes are required to induce the tumorigenic phenotype. 18 Detection of speci®c HPV DNA sequences in human prostate specimens by polymerase chain reaction (PCR) has indicated a possible role for this viral factor in prostate carcinoma. 19 ± 21 However, an etiological role for HPV in prostate carcinoma cancer has not been established. 22, 23 In an attempt to develop an in vitro model of carcinogenesis of the prostate, introduction of HPV DNA into HPE cells would be of special interest because of the immortalization potential of HPV and its possible link with prostate cancer etiology. It has been reported that HPV-immortalized HPE cells are more likely to retain growth and differential characteristics of normal prostate epithelial cell as shown in HPV immortalized human epithelial cells. 24, 25 This approach has resulted in the establishment of HPE cell lines by Weijerman et al 26 and Rhim et al 12 (Table 1) .
Generation and characterization of immortal HPE cell lines derived from primary cancer specimens by HPV-16 E6 E7
The generation of immortal HPE cell cultures that will accurately re¯ect the in situ characteristics of benign or malignant prostate epithelium is imperative. Herein, we described a method 27 that was successful in generating 14 immortal benign or malignant prostate epithelial cell cultures from primary andenocarcinomas of the prostate resected for six successive patients. Immortalization with the E6 and E7 transforming genes of HPV-16 was necessary to establish long-term cultures. Microscopic examination of fresh tumor specimens exhibited a variable mixture of benign and malignant epithelium. Thus, single-cell cloning of tumor-derived cell cultures was essential for de®ning tumor cell lines. Efforts to characterize these cultures using traditional criteria such as karyotype, growth in nude mice and PSA expression were noninformative. However, allelic loss of heterozygosity (LOH) represents a powerful alternative method for characterizing tumor cell lines originating from primary adenocarcinomas of the prostate.
Microdissected fresh tumors from four of six patients revealed LOH at multiple loci on chromosome 8p, as assessed by PCR. LOH on chromosome 8p matching the pattern found in microdissected tumors was observed in a tumor-derived cell line and its clones, as well as in one clone from a different tumor-derived cell line. LOH was not observed in immortal lines generated from autologous benign prostate epithelium, seminal vesicle epithelium or ®broblasts from the same patients. The mulitfocal nature of prostate cancer, as well as the presence of an entire spectrum of malignant transformation within individual prostate glands necessitates this type of careful analysis of derivative cell cultures for their validation as in vitro models that accurately re¯ect the primary cancers from which they were derived.
Efforts to generate de®ned immortalized cell cultures from both malignant and normal prostate epithelial cells are critical to ongoing studies on the pathogenesis of prostate cancer. Such reagents are essential to the biologic and genetic studies that will accelerate the development of new forms of prevention and therapy for this disease.
Immortalization and transformation of HPE cells by a combination of HPV-18 and v-Ki-ras
Recent molecular studies have suggested roles for both the activates ras oncogenes and human papilloma virus (HPV) in prostate carcinogenesis. Increased expression of the ras p21 protein was associated with an increase in histological grade of human prostate cancer. 28, 29 Although a relatively high frequency (24%) of ras mutations has recently been detected in Japanese prostate cancer patients, 20 ras mutations occur infrequently (less than 5%) in prostate cancer specimens of US origin. 30, 31 In a group of Canadian patients, McNicol and Dodd, 19 by using the sensitive PCR, observed a high prevalence of high-risk HPV-16 and/or HPV-18 DNAs. Increased levels of HPV-16 DNA in a sublet of prostate cancer in German patients have recently been reported using the single tube nested competitive PCR method. 32 Whether oncogenic HPVs are involved in the pathogenesis of prostate cancer has been a subject of great controversy. Nonetheless, at least among Japanese men with prostate cancer, ras gene mutations and presence of high-risk HPV DNA sequences have been linked at a relatively high frequency. 20 To obtain further insight into the mechanisms of prostate carcinogenesis, we used newly developed tissue culture methods to ascertain whether HPV-18 or Kirstein murine sarcoma virus (Ki-MuSV) containing an activated Ki-ras oncogene could confer a malignant phenotype on early-passage HPE cells. We reported the immortalization of normal HPE cells grown in serum-free medium by polybrene-induced DNA transfection of the HPV-18 genome and subsequent conversion of such non tumorigenic but immortalized cells into tumorigenic cells by the introduction of an activated Ki-ras oncogene 7 (Table 2) . Our ®ndings represent the malignant transformation of adult HPE cells in culture and support previous epidemiological studies that have implicated the Ki-ras oncogene and HPV infection in prostatic carcinogenesis. The results also show that successive changes are required to induce malignant tumor formation of HPE cells of adult origin that are the natural target of prostate carcinogenesis. Activated Ki-ras was introduced into pRNS-1 1 (Rhim et al, unpublished data) and 267B 1 cells 33 by infection with Ki-MuSV, similarly, morphological alteration and anchorage-independent growth were observed: when cells were injected into nude mice, tumors developed.
Malignant transformation of HPV-18 immortalized HPE (HPV-18 C-1) cell line by NMU
As with other cancers, there is strong evidence for both genetic and environmental factors in the etiology of prostate cancer, with the majority of cases being a result of the interaction of the two. 34 The availability of an HPE cell line that could undergo neoplastic conversion in response to a ras oncogene led us to inquire whether this system might be useful in detecting chemical carcinogens for HPE cells. We have recently succeeded in the malignant transformation of HPV-18 immortalized by nontumorigenic adult HPE (HPV-18 C-1) cells after multiple exposures to the chemical carcinogen, N-nitroso-Nmethylurea (NMU). 35 In the HPV-18 C-1 line exposed three times to NMU, altered morphology was observed by the third subcultures (4 ± 5 weeks after treatment). Similar changes were not observed in the control HPV-18 C-1 cells treated with DMSO. Changes were ®rst observed in the cells treated with NMU at 3 6 100 mg/ml; however, alterations in the cells treated with NMU at 3 6 50 mg/ml because more pronounced after further subcultivation. Such transformants showed anchorageindependent growth in soft agar. When these morphologically altered cells were inoculated into 129 J nude mice or SCID mice, the animals developed tumors. The NMU 3 6 50 mg/ml-treated cells were highly tumorigenic (5/5). The mice inoculated with these transformed cells developed tumors within 3 months. However, the NMU 3 6 100 mg/ml cells were less tumorigenic. They produced tumors after 4 months in one of four athymic nude mice. Microscopic examination of these tumors revealed poorly differentiated carcinomas consistent with prostate cancer. Cultures established from these tumors (129Nu5002-1 Tu and 129Nu5010-5 Tu) resembled the NMU-transformed cells, and were con®rmed as human and to resemble the cells of origin by karyological analysis. In contrast, the immortalized HPV-18 C-1 cells, as well as the cells treated with 3 6 250 mg/ml NMU, were nontumorigenic for up to 6 months after s.c. inoculation in athymic nude mice or SCID mice.
These results appear to represent the ®rst malignant transformation of human prostate cells in culture by the cumulative action of HPV-18 and the chemical carcinogen NMU. At least two and possible more alterations in cell growth properties seem to be required. The measurable event was the development of apparently unlimited growth potential as a result of HPV-18 immortalization. Treatment of nontumorigenic early-passage HPV-18 immortalized HPE cells with NMU resulted in further changes in their phenotypic properties, including morphological alterations, the ability to grow in soft agar, and the formation of tumors in the athymic mice.
In this model system, the chemical carcinogen is similar to the v-Ki-ras oncogene in its ability to complement HPV-18 in fully transforming HPE cells. However, unlike the rapid transformation of HPV-18 C-1 cells observed after v-Ki-ras infection, 7 the alterations in the growth patterns after NMU treatment were delayed in their appearances and required several subcultivations for visualization. These ®ndings suggest that multiple cell divisions are required for ®xation and expression of the transformed phenotype in response to the chemical carcinogen. HPV, human papillomavirus; NMU, N-nitroso-N-methylurea; ND, not done.
In vitro human cell culture models JS Rhim
It is possible that more than one genetic lesion may be required as well. Cooperating cellular or viral oncogenes have been shown to induce neoplastic transformation of embryonic rodent ®broblasts. 36, 37 In addition, the combined action of HPV-18 and NMU in the induction of squamous cell carcinoma has been shown. 38 Our data on neoplastic transformation of HPV-18-immortalized HPE cells by exposure to NMU provides additional support for the theory that neoplastic conversion is a multistep process. This system may be useful in evaluating the carcinogenic potential of environmental chemicals for studying genes that are activated or suppressed in the multistep process leading to malignancy.
NO p53 and ras mutations in the NMU transformed HPE (HPV-18 C-1) cells
Radioimmunoprecipitation analysis of the cellular ras protein with anti-p21 antiserum revealed no differences in migration patterns or band intensities in the untreated and chemical-treated cells. To determine if the alteration of cellular ras (K-ras, H-ras and N-ras) and p53 genes is present in the chemical-transformed HPV-18 C-1 cells and tumor cell lines, RT-PCR and SSCP analyses were performed. SSCP analysis of cellular ras genes displayed identical banding patterns in these cells as compared to the control. A similar PCR-SSCP analysis for exons 2 ± 11 of the p53 gene revealed no mutation in the HPV-18 C-1 parental, chemical-transformed or tumorigenic cells, indicating that no deletions, point mutations or rearrangements were present. 35 The possibility that alterations in cellular oncogene expression, speci®cally ras, which is known to be potentially altered by nitroso compounds, 39 were involved in the conversion of these cells to a malignant phenotype has been considered. The neoplastic transformation of the HPV-18 C-1 cell by NMU suggests that other cellular oncogenes may be activated as part of the process. Our ®ndings indicate that ras oncogenes were not activated in this chemical-induced transformation even though ras oncogenes have been implicated in chemical carcinogeninduced animal tumor 40 and in some human prostate carcinomas. 20, 41 This system may be useful in efforts to detect and characterize other cellular genes contributing to the neoplastic phenotype of HPE cells.
Alterations of the tumor suppressor gene p53 have been associated with malignant transformation in human and animal systems, 42, 43 and also implicated in the pathogenesis of prostate cancer. 44 Loss of genetic material from the distal portion of chromosome 17p in three of 18 human prostate cancers has been shown. 45 Expression of wild-type p53 in prostate cancer cell lines with mutation alleles will suppress their growth. 44 However, an uncertain role for p53 gene alteration in 55 clinical human prostate cancers has recently been reported. 46 Our analysis of exons 2-11 of the p53 gene in the parental HPV-18 C-1, NMU-treated and tumorigenic lines, indicates an absence of point mutations, deletions or rearrangement in this tumor suppressor gene. This ®nding suggests a different pathway involved in the carcinogenic progression of these cells.
Chromosome changes in tumor cell lines derived from NMU transformed HPE (HPV-18 C-1) cells
Cytogenetic studies showed that stepwise chromosomal changes in the progression to tumorigenicity were observed (Table 3) . Two clonal populations were observed in the immortalized HPV-18 C-1 cells at passage 17. There was a major population in which the chromosome numbered in the 50s (51%) and a minor population in the 40s (25%). These two cloned lines differed from each other in chromosome changes. The cell lines treated with different concentration of the chemical NMU showed similar changes. Only the 40s clonal population was selected in NMU-treated cell lines. Numerous chromosomal defects were noted on karyotypes after chemical exposure. However, in the case of two independently derived tumor cell lines from the 3 6 50 mg/ml NMU-exposed culture compared to immortalized and NMU-transformed cell lines, there was further loss of the chromosomes 8 (p10 b pter) 47, 52, 53 and chromosome 10p, 47,51 the potential sites for prostate cancer-associated tumor suppressor genes. The gain of chromosome 8q suggested that the presence of an activated oncogene (eg c-myc) 34 is only reported by new methods of comparative genomic hybridization. 53 The loss of chromosomes 8p and 10p and the gain of chromosome 8q observed speci®cally in the tumorigenic cell lines in the present study leads us to believe that these regions must be important in the progression to malignancy. Our recent PCR analysis also revealed allelic loss at multiple loci 8p and 10p. Moreover, two of three HPV-16 E6 ± E7 immortalized tumor cell lines originating from primary adenocarcinomas of the prostate 26 also demonstrated extensive loss of 8p sequences by LOH analysis. These data suggest that 8p and 10p loss comprises some of the most commonly documented genetic changes in transformed prostate tissues, and that in NMU-induced test system may comprise a powerful model for studying the molecular biology of prostate cancer progression. We have indeed created tumor cell lines that re¯ect the true characteristics of primary prostate cancer specimens obtained directly from patients. Additional molecular analysis of these cells will be needed to determine the speci®c events that are responsible for malignant transformation.
One of our major research goals is the identi®cation of the stepwise molecular alterations underlying prostate carcinogenesis. The cDNA array will be applied to screen and search for differentially expressed genes between nontumorigenic, immortalized and tumorigenic cell lines.
Conclusion
As I have discussed above, the number of in vitro human cell culture models of prostate carcinogenesis has greatly increased. These include representation of normal, immortal, tumorigenic and metastic phenotypes. Immortalization and tumorigenic conversion of normal HPE cell with SV40, HPV, oncogenes, radiation and chemical carcinogen has been demonstrated. Using these model systems, investigators have identi®ed genetic and molecular changes that occur as a prostatic epithelial cells progressively change from normal to immortal, then tumorigenic and ®nally metastatic. Some of the changes that occur are directly related to the activities of the particular oncogene used for transformation. For example, p53 is constitutively overexpreseed in SV40 transformed cells as a result of banding and stabilization of p53 by large T-antigen. Other changes may be intrinsic to prostate cells and possibly mimic changes that actually occur in the development of prostate cancer. When we created tumorigenic subline of HPV-transformed HPE cells by treatment with NMU, we found the loss of chromosomes 8p and 10p and gain of chromosome 8q. These are among the most frequent cytogenic changes in prostate cancer. Therefore, in vitro models of carcinogenesis may accurately re¯ect key processes involved in prostate cancer. However, these models are not ideal because the immortalizing cells frequently contain viral oncogenic DNA and accompany major cytogenic alterations and growth deregulation. The immortalizing agents (SV40 and HPV) may introduce many genetic and epigenetic artifacts into these cells, making it dif®cult to investigate speci®c alterations unique to tumors. Development of in vitro human cell models that mimic human prostate cancer progression would be ideal. SV40 and HPV infection do not appear to be related to prostate cancer development. Whether oncogenic HPVs are involved in the pathogenesis of prostate cancer has been a subject of great controversy. Conceptually, successful establishment of spontaneously immortalized human prostate cancer cell lines derived from patients would be an ideal and major breakthrough in prostate cancer research. However, the generation of such cell lines has not been reported.
